Islet amyloid polypeptide gene promoter polymorphisms are not associated with Type 2 diabetes or with the severity of islet amyloidosis

Clark, 1987, Islet amyloid formed from diabetes-associated peptide may be pathogenic in type-2 diabetes, Lancet, 2, 231, 10.1016/S0140-6736(87)90825-7 Westermark, 1994, Amyloid and polypeptide hormones: what is their interrelationship?, Int. J. Exp. Clin. Invest., 1, 47 Schneider, 1980, Das amyloid der langerhansschen inseln und seine beziehung zum diabetes mellitus, Dtsch. Med. Wochenschr., 105, 1143, 10.1055/s-2008-1070828 de Koning, 1993, Diabetes mellitus in Macaca mulatta monkeys is characterised by islet amyloidosis and reduction in beta-cell population, Diabetologia, 36, 378, 10.1007/BF00402271 O'Brien, 1986, Immuno-histochemical morphometry of pancreatic endocrine cells in diabetic normoglycaemic glucose-intolerant and normal cats, J. Comp. Pathol., 96, 357, 10.1016/0021-9975(86)90031-9 Wang, 2001, Islet amyloid develops diffusely throughout the pancreas before becoming severe and replacing endocrine cells, Diabetes, 50, 2514, 10.2337/diabetes.50.11.2514 German, 1992, The insulin and islet amyloid polypeptide genes contain similar cell-specific promoter elements that bind identical beta-cell nuclear complexes, Mol. Cell. Biol., 12, 1777, 10.1128/MCB.12.4.1777 Clark, 2004, Islet amyloid: a complication of islet dysfunction or an aetiological factor in Type 2 diabetes?, Diabetologia, 47, 157, 10.1007/s00125-003-1304-4 Novials, 2001, A novel mutation in islet amyloid polypeptide (IAPP) gene promoter is associated with Type II diabetes mellitus, Diabetologia, 44, 1064 Novials, 2004, Mutation at position −132 in the islet amyloid polypeptide (IAPP) gene promoter enhances basal transcriptional activity through a new CRE-like binding site, Diabetologia, 47, 1167, 10.1007/s00125-004-1439-y Poa, 2003, Amylin gene promoter mutations predispose to Type 2 diabetes in New Zealand Maori, Diabetologia, 46, 574, 10.1007/s00125-003-1068-x Pildal, 2003, Studies of variability in the islet amyloid polypeptide gene in relation to type 2 diabetes, Diabet. Med., 20, 491, 10.1046/j.1464-5491.2003.00951.x Gloyn, 2002, Human calcium/calmodulin-dependent protein kinase II gamma gene (CAMK2G): cloning, genomic structure and detection of variants in subjects with type II diabetes, Diabetologia, 45, 580, 10.1007/s00125-002-0779-8 MacNamara, 2000, Parallel changes of proinsulin and islet amyloid polypeptide in glucose intolerance, Diabetes Res. Clin. Pract., 50, 117, 10.1016/S0168-8227(00)00188-1 Percy, 1996, Development of sensitive immunoassays to detect amylin and amylin-like peptides in unextracted plasma, Clin. Chem., 42, 576, 10.1093/clinchem/42.4.576 Kahn, 1998, Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans, Diabetes, 47, 640, 10.2337/diabetes.47.4.640 Carty, 1997, Identification of cis- and trans-active factors regulating human islet amyloid polypeptide gene expression in pancreatic beta-cells, J. Biol. Chem., 272, 11986, 10.1074/jbc.272.18.11986 Macfarlane, 2000, Glucose regulates islet amyloid polypeptide gene transcription in a PDX1- and calcium-dependent manner, J. Biol. Chem., 275, 15330, 10.1074/jbc.M908045199 Lehto, 1992, Could a mutation in the amylin gene promoter region explain hyperamylinemia in individuals predisposed to NIDDM?, Diabetes, 41, A334 Westermark, 1972, Quantitative studies on amyloid in the islets of Langerhans, Ups. J. Med. Sci., 91, 10.1517/03009734000000014 Maloy, 1981, The relation of islet amyloid to the clinical type of diabetes, Human Pathol., 12, 917, 10.1016/S0046-8177(81)80197-9 Clark, 1984, Non-uniform distribution of islet amyloid in the pancreas of ‘maturity-onset’ diabetic patients, Diabetologia, 27, 527, 10.1007/BF00290389 Birch, 1997, The S20G islet-associated polypeptide gene mutation in familial NIDDM, Diabetologia, 1113 Sakagashira, 1996, Missense mutation of amylin gene (S20G) in Japanese NIDDM patients, Diabetes, 1279, 10.2337/diab.45.9.1279 Seino, 2001, S20G mutation of the amylin gene is associated with Type II diabetes in Japanese. Study group of comprehensive analysis of genetic factors in diabetes mellitus, Diabetologia, 906, 10.1007/s001250100531 Sakagashira, 2000, S20G mutant amylin exhibits increased in vitro amyloidogenicity and increased intracellular cytotoxicity compared to wild-type amylin, Am. J. Pathol., 157, 2101, 10.1016/S0002-9440(10)64848-1